Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Justera Health Ltd C.VTAL

Alternate Symbol(s):  SCRSF

Justera Health Ltd. is a Canadian company focused on health and wellness. It offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Its Concierge Medical business provides discreet and personalized concierge healthcare services, including IV Vitamin Therapy. Its services include Screenpro Security, Justera Health Product, Naturevan, Juillet Wellness, and TRINITI Corporation. It is also specialized in providing efficient COVID-19 testing and same-day test results through its Canadian labs. It offers two convenient methods to test: in clinic testing or mobile at home testing. It is a distributor of TonyMoly skin care products in Canada. It provides a full-service wellness center, providing a range of beauty and wellness services.


CSE:VTAL - Post by User

Comment by WalkingDead01on Jun 26, 2021 6:48am
158 Views
Post# 33455548

RE:Is anybody else contemplating to double down at .035?

RE:Is anybody else contemplating to double down at .035?

CriticalMind55 wrote: Another opportunity that I see for SCRN is a strong team of nurses and doctors that can be deployed to anywhere in the world to provide many different services given different situations, so their business will not be all end all COVID, possibilities are endless and sustainable, reoccurring revenue beyond COVID is achievable.



I'm happy with the cancellation of the deal with Centred, I think it was McMullen's idea but not Ryu's.  We have had several news this week which gives us a good overview of the situation.  I believe Ryu is working to reverse the trend quickly and I expect more news in the near term which may confirm the double low at .035 and start rising again and restore confidence.  In terms of deploying the SCRN teams around the world, there was the news of March 10 which was related to what you are suggesting, however we have not had any new information on this so we should ask Ryu about it.

 

 

ScreenPro Approved to Bid on NHS London UK Supply Tender

 

Toronto, Ontario - March 10, 2021 - Compel Capital o/a ScreenPro Security (CSE: SCRN) ("ScreenPro" or the "Company"), is pleased to inform its shareholders that the company, through its partnership with Enoura Medical in United Kingdom, has been approved by the National Health Service (NHS) in London UK and is now eligible to bid on NHS contracts by offering its suite of services and products.

 
 
 

The NHS of London is the medical agency for the City of London tasked with ensuring the medical health and safety of all of its 9.4 million citizens. To become a qualified supplier, the entity and its product offering have to be stringently reviewed and approved by the National Health Service (NHS) prior to bidding.

 
 
 

Enoura Medical has been working with ScreenPro for the last five months positioning the Company to provide solutions to the growing issues challenging London. For example, it is estimated that the overall value of the NHS tender for the city of London alone, is over 900 million GBP (equivalent to $1.574 Billion CDN) and illustrates how the country is preparing to screen its citizens for all variants of the virus for the next two years.


 

<< Previous
Bullboard Posts
Next >>